Nitrated {alpha}-synuclein-induced alterations in microglial immunity are regulated by CD4+ T cell subsets

Author(s): Reynolds AD, Stone DK, Mosley RL, Gendelman HE

Abstract

Microglial inflammatory responses affect Parkinson's disease (PD) associated nigrostriatal degeneration. This is triggered, in measure, by misfolded, nitrated alpha-synuclein (N-alpha-syn) contained within Lewy bodies that are released from dying or dead dopaminergic neurons into the extravascular space. N-alpha-syn-stimulated microglial immunity is regulated by CD4+ T cell subset. Indeed, CD4+CD25+ regulatory T cells (Treg) induce neuroprotective immune responses. This is seen in rodent models of stroke, amyotrophic lateral sclerosis, human immunodeficiency virus associated neurocognitive disorders, and PD. To elucidate the mechanism for Treg-mediated microglial neuroregulatory responses, we used a proteomic platform integrating difference gel electrophoresis and tandem mass spectrometry peptide sequencing. These tests served to determine consequences of Treg on the N-alpha-syn stimulated microglia. The data demonstrated that Treg substantially alter the microglial proteome in response to N-alpha-syn. This is seen through Treg abilities to suppress microglial proteins linked to cell metabolism, migration, protein transport and degradation, redox biology, cytoskeletal, and bioenergetic activities. We conclude that Treg modulate the N-alpha-syn microglial proteome and, in this way, can slow the tempo and course of PD.

Similar Articles

Neuroprotective activities of CD4+CD25+ regulatory T cells in an animal model of Parkinson's disease

Author(s): Reynolds AD, Banerjee R, Liu J, Gendelman HE, Mosley RL

Alterations of T-lymphocyte populations in Parkinson disease

Author(s): Baba Y, Kuroiwa A, Uitti RJ, Wszolek ZK, Yamada T

Lymphocyte populations in Parkinson's disease and in rat models of parkinsonism

Author(s): Bas J, Calopa M, Mestre M, Molleví DG, Cutillas B, et al.

Apoptosis of peripheral blood lymphocytes in Parkinson patients

Author(s): Calopa M, Bas J, Callén A, Mestre M

The ABC of the blood-brain barrier - regulation of drug efflux pumps

Author(s): Mahringer A, Ott M, Reimold I, Reichel V, Fricker G

Blood-brain barrier leakage may lead to progression of temporal lobe epilepsy

Author(s): van Vliet EA, da Costa Araújo S, Redeker S, van Schaik R, Aronica E, et al.

Blood-brain barrier disruption in multiple sclerosis

Author(s): Minagar A, Alexander JS

The role of neuroinflammation on the pathogenesis of Parkinson's disease

Author(s): Chung YC, Ko HW, Bok E, Park ES, Huh SH, et al.

Decreased blood-brain barrier P-glycoprotein function in the progression of Parkinson's disease, PSP and MSA

Author(s): Bartels AL, Willemsen AT, Kortekaas R, de Jong BM, de Vries R, et al.

Attenuation of AD-like neuropathology by harnessing peripheral immune cells: local elevation of IL-10 and MMP-9

Author(s): Koronyo-Hamaoui M, Ko MK, Koronyo Y, Azoulay D, Seksenyan A, et al.

Proteomic studies of nitrated alpha-synuclein microglia regulation by CD4+CD25+ T cells

Author(s): Reynolds AD, Stone DK, Mosley RL, Gendelman HE

Leptin and ghrelin concentrations and weight loss in Parkinson's disease

Author(s): Fiszer U, Michałowska M, Baranowska B, Wolińska-Witort E, Jeske W, et al.

Innate and adaptive immunity for the pathobiology of Parkinson's disease

Author(s): Stone DK, Reynolds AD, Mosley RL, Gendelman HE

Immunoprotection against toxic biomarkers is retained during Parkinson's disease progression

Author(s): Gruden MA, Sewell RD, Yanamandra K, Davidova TV, Kucheryanu VG, et al.

Anti-melanin antibodies are increased in sera in Parkinson's disease

Author(s): Double KL, Rowe DB, Carew-Jones FM, Hayes M, Chan DK, et al.

Effects of alpha-synuclein immunization in a mouse model of Parkinson's disease

Author(s): Masliah E, Rockenstein E, Adame A, Alford M, Crews L, et al.

Human interleukin-10 gene transfer is protective in a rat model of Parkinson's disease

Author(s): Johnston LC, Su X, Maguire-Zeiss K, Horovitz K, Ankoudinova I, et al.

α-Synuclein and dopamine at the crossroads of Parkinson's disease

Author(s): Venda LL, Cragg SJ, Buchman VL, Wade-Martins R

Immunocytochemical analysis of tumor necrosis factor and its receptors in Parkinson's disease

Author(s): Boka G, Anglade P, Wallach D, Javoy-Agid F, Agid Y, et al.

T-cells in Alzheimer's disease

Author(s): Town T, Tan J, Flavell RA, Mullan M